Natural Product: NPC300149

Natural Product IDNPC300149
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
VOUJHLROTVTYMT-UHFFFAOYSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 636743
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0002497] Indoles

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VOUJHLROTVTYMT-UHFFFAOYSA-N
Standard InCHI InChI=1S/C18H12N2O2/c21-17(13-9-19-15-7-3-1-5-11(13)15)18(22)14-10-20-16-8-4-2-6-12(14)16/h1-10,19-20H
SMILES c1ccc2c(c1)c(c[nH]2)C(=O)C(=O)c1c[nH]c2ccccc12

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   288.09 Volume:   298.868
?
Van der Waals volume.
Dense:   0.964 LogP:   3.319
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.78
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.628
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   22.0
TPSA:   65.72
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.446 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.119 Fsp3:   0.0
MCE-18:   20.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   1
Colloidal aggregators:   0.891 Fluc inhibitor:   0.947
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.279
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.593
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.368 Promiscuous compounds:   0.975

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.803 MDCK Permeability:   -4.64
Pgp-inhibitor:   0.984 Pgp-substrate:   0.0
PAMPA:   0.244
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.353
20% Bioavailability (F20%):   0.003 30% Bioavailability (F30%):   0.818
50% Bioavailability (F50%):   0.635

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.003
Plasma Protein Binding (PPB):   96.73% Volume Distribution (VD):   -0.017
Fu: 2.745%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.984
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.443
BSEP inhibitor:   0.995

ADMET: Metabolism

CYP1A2-inhibitor:   0.048 CYP1A2-substrate:   1.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.813
CYP2C9-inhibitor:   0.108 CYP2C9-substrate:   0.993
CYP2D6-inhibitor:   0.915 CYP2D6-substrate:   0.994
CYP3A4-inhibitor:   0.013 CYP3A4-substrate:   0.024
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.969
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.555 Half-life (T1/2):  0.849

ADMET: Toxicity

hERG Blockers:  0.196 hERG Blockers (10um):  0.572
Human Hepatotoxicity (H-HT):  0.641 Drug-induced Liver Injury (DILI):  0.737
AMES Toxicity:  0.685 Rat Oral Acute Toxicity:  0.53
Maximum Recommended Daily Dose:  0.516 Skin Sensitization:  0.194
Carcinogencity:  0.582 Eye Corrosion:  0.027
Eye Irritation:  0.964 Respiratory Toxicity:  0.669
Drug-induced Neurotoxicity:  0.799 Ototoxicity:  0.385
Hematotoxicity:  0.44 Drug-induced Nephrotoxicity:  0.451
Genotoxicity:  0.545 RPMI-8226 Immunitoxicity:  0.053
A549 Cytotoxicity:  0.177 Hek293 Cytotoxicity:  0.212
BCF:   1.41
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.378
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.619
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.572
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[11076576]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota Melia azedarach n.a. n.a. PMID[21353539]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[24183988]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[33180497]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[8988601]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO21538 Fusarium sp. Species Nectriaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6638 Individual protein Pyruvate kinase Staphylococcus aureus (strain MRSA252) IC50 = 50200.0 nM PMID[25266785]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT22368 Organism Zika virus Zika virus EC50 = 5000.0 nM PMID[33180497]
NPT22368 Organism Zika virus Zika virus EC50 = 4200.0 nM PMID[34438338]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC300149 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8056 Intermediate Similarity NPC154339
0.6829 Remote Similarity NPC267343
0.6667 Remote Similarity NPC42372
0.6471 Remote Similarity NPC261195
0.6216 Remote Similarity NPC230002
0.6154 Remote Similarity NPC138370
0.6 Remote Similarity NPC72435
0.5946 Remote Similarity NPC216643
0.5946 Remote Similarity NPC288838
0.5946 Remote Similarity NPC601214
0.5789 Remote Similarity NPC105127
0.5789 Remote Similarity NPC53947
0.5789 Remote Similarity NPC102423
0.575 Remote Similarity NPC230869
0.575 Remote Similarity NPC279081
0.561 Remote Similarity NPC276657
0.56 Remote Similarity NPC476460
0.5581 Remote Similarity NPC67288
0.5581 Remote Similarity NPC310665
0.5556 Remote Similarity NPC74413
0.55 Remote Similarity NPC131718
0.55 Remote Similarity NPC96102
0.549 Remote Similarity NPC99939
0.5455 Remote Similarity NPC603879
0.5385 Remote Similarity NPC308931
0.5349 Remote Similarity NPC111275
0.5238 Remote Similarity NPC29886
0.5238 Remote Similarity NPC601179
0.5238 Remote Similarity NPC604154
0.5227 Remote Similarity NPC605863
0.5217 Remote Similarity NPC315555
0.5217 Remote Similarity NPC55772
0.5217 Remote Similarity NPC600736
0.5217 Remote Similarity NPC602656
0.5217 Remote Similarity NPC605085
0.5116 Remote Similarity NPC84911
0.5116 Remote Similarity NPC608908

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC300149 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.55 Remote Similarity NPD198 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data